MEDIUM confidence: 100% data completeness, but the composite (52) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9.9B— | $11.1B+11.8% | $12.6B+13.6% | $14.6B+15.8% | $17.0B+16.6% |
| EPS (dil.) | $7.06— | $8.10+14.7% | $13.31+64.3% | $21.52+61.7% | $28.19+31.0% |
| Free Cash Flow | $283M— | $449M+58.7% | $821M+83.1% | $1.3B+62.3% | $1.2B-10.8% |
| Gross Margin | 15.2% | 14.5%-0.7pp | 16.6%+2.1pp | 19.0%+2.4pp | 19.3%+0.3pp |
| Operating Margin | 5.4% | 5.1%-0.3pp | 7.0%+1.9pp | 9.2%+2.3pp | 10.1%+0.9pp |
| Net Margin | 3.9% | 3.7%-0.2pp | 5.0%+1.4pp | 6.9%+1.9pp | 7.5%+0.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 7.7%/yr (revenue basis).
Base free cash flow $1.1B (avg FY2023–FY2025; latest year $1.2B) · equity value $29.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $1031 avg across 5 analysts.
Buy-rated share 70% → 64% over ~3 months (-6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $8.37 | $9.60 | +14.7% |
| Jul 2026 | $7.23 | $9.06 | +25.3% |
| Apr 2026 | $5.90 | $6.84 | +15.9% |
| Feb 2026 | $6.68 | $7.19 | +7.6% |
| Oct 2025 | $6.54 | $6.57 | +0.5% |
| Jul 2025 | $5.74 | $6.72 | +17.1% |
| Apr 2025 | $4.63 | $5.41 | +16.8% |
| Feb 2025 | $5.53 | $6.32 | +14.3% |
Net insider -$2.7M over 180 days (2 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 52 for EME suggests a neutral outlook, driven by its strong value and growth profiles, with a P/E of 19.5 and revenue growth of 16.6%. However, momentum scores are dragged down by a 12-month return of -13.3% and a bearish 50-day versus 200-day moving average trend. The long-term and short-term scores diverge by 7 points, with the long-term score being slightly higher at 55. EME's profitability also exhibits strong metrics, including an ROE near 39%.